CAI — CARIS LIFE SCIENCES INC

Ownership history in Freestone Grove Partners LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in CARIS LIFE SCIENCES INC (CAI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2025 Q3)
Avg. % of fund
0.03%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 251,389 +201,389 +402.8% 0.06% $7.6M $30.25
2025 Q2 INITIATED 50,000 — — 0.01% $1.3M $26.72
% of Fund (quarterly)    CAI price (monthly, adj. close)

Other funds also holding CAI

As of 2025 Q4 — sorted by position size

Sixth Street Partners Management Company, L.P. 3Y 53.72% PURA VIDA INVESTMENTS, LLC 3Y 7Y 9.07% BRAIDWELL LP 3Y 6.74% Longaeva Partners L.P. 3.42% ORBIMED ADVISORS LLC 3Y 7Y 1.72% Sandia Investment Management LP 3Y 1.59% Ghisallo Capital Management LLC 3Y 1.02% SEVEN GRAND MANAGERS, LLC 3Y 1.02% Rock Springs Capital Management LP 3Y 7Y 0.95% HAMILTON LANE ADVISORS LLC 3Y 7Y 0.87%
← Back to Freestone Grove Partners LP Holdings